Chemistry: analytical and immunological testing – Involving immune complex formed in liquid phase – Signal modification or steric inhibition
Patent
1998-05-21
2000-05-23
Ceperley, Mary E.
Chemistry: analytical and immunological testing
Involving immune complex formed in liquid phase
Signal modification or steric inhibition
436546, 436815, 436816, 436825, G01N 33542, G01N 33533
Patent
active
06066505&
ABSTRACT:
In a fluorescence polarization assay for determining the amount of a target analyte in a test sample, wherein the amount of analyte is related to the amount of fluorescence emitted from the analyte-containing reagent medium, the improvement comprising contacting the analyte-containing reagent medium with of at least one compound from the group consisting of 1,10-phenanthroline, 8-hydroxy-7-iodo-5-quinoline, naphthalene-1-sulfonic acid, salts thereof, and any combination thereof.
REFERENCES:
patent: 4252783 (1981-02-01), Kam et al.
patent: 4492762 (1985-01-01), Wang et al.
The Merck Index of Chemicals and Drugs, Seventh Edition. Merck & Co., Inc. NJ, USA, p. 791, 1960.
Dandliker, W. B. and Feigen, G. A., Quantification of the Antigen-Antibody Reaction by the Polarization of Fluorescence, 1961, vol. 5, No. 4, 299-304 .
Cheng Charles
Schwenzer Kathryn Sarah
Wong Raymond Thomas
Amink Marilyn L.
Ceperley Mary E.
Roche Diagnostics Corporation
LandOfFree
Fluorescence polarization immunoassay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorescence polarization immunoassay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorescence polarization immunoassay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1836240